Here, we show that cytoplasmic REDD1 overexpression is an independent prognosis factor for ovarian cancer in 229 ovarian cancer specimens analyzed by multivariate Cox proportional hazards regression, indicating that REDD1 might be a prognostic biomarker for ovarian cancer patients. This evidence concerns the gene DDIT4 and ovarian carcinoma.